These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 9712353

  • 1. IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes.
    Couper JJ, Harrison LC, Aldis JJ, Colman PG, Honeyman MC, Ferrante A.
    Hum Immunol; 1998 Aug; 59(8):493-9. PubMed ID: 9712353
    [Abstract] [Full Text] [Related]

  • 2. Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens.
    Füchtenbusch M, Kredel K, Bonifacio E, Schnell O, Ziegler AG.
    Diabetes; 2000 Jun; 49(6):918-25. PubMed ID: 10866043
    [Abstract] [Full Text] [Related]

  • 3. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC, Stone N, de Aizpurua H, Rowley MJ, Harrison LC.
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [Abstract] [Full Text] [Related]

  • 4. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives.
    Chen QY, Rowley MJ, Byrne GC, Jones TW, Tuomi T, Knowles WJ, Zimmet PZ, Mackay IR.
    Pediatr Res; 1993 Dec; 34(6):785-90. PubMed ID: 8108194
    [Abstract] [Full Text] [Related]

  • 5. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes.
    DeAizpurua HJ, Honeyman MC, Harrison LC.
    J Autoimmun; 1992 Dec; 5(6):759-70. PubMed ID: 1489487
    [Abstract] [Full Text] [Related]

  • 6. IgG1 is the dominant subclass of antibody against glutamic acid decarboxylase among type 1 diabetes in Japanese.
    Kasuga A, Shimada A, Ozawa Y, Maruyama T, Oya K, Saruta T.
    Endocr J; 2000 Feb; 47(1):57-62. PubMed ID: 10811294
    [Abstract] [Full Text] [Related]

  • 7. IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autoimmune diabetes in adults than in type 1 diabetes.
    Hillman M, Törn C, Thorgeirsson H, Landin-Olsson M.
    Diabetologia; 2004 Nov; 47(11):1984-9. PubMed ID: 15565370
    [Abstract] [Full Text] [Related]

  • 8. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
    Sabbah E, Kulmala P, Veijola R, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Akerblom HK, Knip M.
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
    [Abstract] [Full Text] [Related]

  • 9. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA, Rabin DU, Rowley MJ.
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [Abstract] [Full Text] [Related]

  • 10. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.
    Thivolet CH, Tappaz M, Durand A, Petersen J, Stefanutti A, Chatelain P, Vialettes B, Scherbaum W, Orgiazzi J.
    Diabetologia; 1992 Jun; 35(6):570-6. PubMed ID: 1612231
    [Abstract] [Full Text] [Related]

  • 11. Immune responses to glutamic acid decarboxylase and insulin in patients with gestational diabetes.
    Füchtenbusch M, Bonifacio E, Lampasona V, Knopff A, Ziegler AG.
    Clin Exp Immunol; 2004 Feb; 135(2):318-21. PubMed ID: 14738462
    [Abstract] [Full Text] [Related]

  • 12. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
    Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF.
    Diabetologia; 1995 Jul; 38(7):816-22. PubMed ID: 7556984
    [Abstract] [Full Text] [Related]

  • 13. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
    Schmidli RS, Colman PG, Harrison LC.
    J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
    [Abstract] [Full Text] [Related]

  • 14. Elimination of islet cell antibodies and glutamic acid decarboxylase antibodies II in a patient with newly diagnosed insulin-dependent diabetes mellitus.
    Richter WO, Donner MG, Schwandt P.
    J Clin Apher; 1997 Dec; 12(4):196-9. PubMed ID: 9483183
    [Abstract] [Full Text] [Related]

  • 15. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes.
    De Aizpurua HJ, Wilson YM, Harrison LC.
    Proc Natl Acad Sci U S A; 1992 Oct 15; 89(20):9841-5. PubMed ID: 1409709
    [Abstract] [Full Text] [Related]

  • 16. Transient IgG subclass deficiencies in newly diagnosed diabetic children.
    Cortona L, Avanzini MA, Martinetti M, Lorini R.
    Eur J Pediatr; 1992 Mar 15; 151(3):179-82. PubMed ID: 1601008
    [Abstract] [Full Text] [Related]

  • 17. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes.
    Harrison LC, Honeyman MC, DeAizpurua HJ, Schmidli RS, Colman PG, Tait BD, Cram DS.
    Lancet; 1993 May 29; 341(8857):1365-9. PubMed ID: 8098789
    [Abstract] [Full Text] [Related]

  • 18. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie M, Scherbaum WA.
    Diabetologia; 1996 Nov 29; 39(11):1351-6. PubMed ID: 8933004
    [Abstract] [Full Text] [Related]

  • 19. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M, Durinovic-Bello I, Ziegler AG.
    J Autoimmun; 1996 Jun 29; 9(3):427-30. PubMed ID: 8816982
    [Abstract] [Full Text] [Related]

  • 20. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study.
    Verge CF, Howard NJ, Rowley MJ, Mackay IR, Zimmet PZ, Egan M, Hulinska H, Hulinsky I, Silvestrini RA, Kamath S.
    Diabetologia; 1994 Nov 29; 37(11):1113-20. PubMed ID: 7867883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.